Is there a synergic effect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study

Heart

Volumn 83, Issue 2, 2000, Pages 172-177

  Garrigue, S ^a   Barold, S S ^b   Cazeau, S ^c   Hocini, M ^a   Jais, P ^a   Haissaguerre, M ^a   Clementy, J ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c Centre Chirurgical Val d'Or   (France)

Author keywords

Atrial arrhythmia; Atrial overdrive pacing; Dual chamber pacing; Propafenone

Indexed keywords

PROPAFENONE;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM PACING; HUMAN; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0034108128     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.2.172     Document Type: Article

References (8)

1. 1 Garrigue S, Barold SS, Cazeau S, et al. Prevention of atrial arrhythmias during DDD pacing by atrial overdrive. PACE 1998;211751-9.
2. 2 Dean AD, Dean JA, Burton JH, et al. Epi Info, version 5: a word processing, database, and statistics program for epidemiology on micro-computers. Atlanta, Georgia: Centers for Disease Control, 1990:82-5.
3. 3 Pritchett ELC, McCarthy EA, Wilkinson WE. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias: a randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. Ann Intern Med 1991; 114:539-44.
4. 4 Kyles AE, Murdock CJ, Yeung-Lai-Wah JA, et al. Long-term efficacy of propafenone for prevention of atrial fibrillation. Can J Cardiol 1991;7:407-9.
5. 5 Hammill SC, Wood DL, Gersh BJ, et al. Propafenone for paroxysmal atrial fibrillation. Am J Cardiol 1988;61:473-4.
6. 6 Podrid PJ, Anderson JL, for the Propafenone Multicenter Study Group. Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias. Am J Cardiol 1996;78:430-4.
7. 7 Schlesselman JJ. Sample size requirements in cohort and case-control studies of disease. Am J Epidemiol 1974;99: 381-1.
8. 8 Rothman KJ, Boice JD. Epidemiologic analysis with a programmable calculator, 2nd ed. Chestnut Hill, MA: Epidemiology Resources Inc, 1982.